April 22, 2013

Study to Treat Deadly Form of Thyroid Cancer Shows Promise, Mayo Clinic Says

By Logan Lafferty

A combination of therapies may prove to be a promising advance for the treatment of anaplastic thyroid cancer based on results of a phase I clinical trial, say researchers at Mayo Clinic in Florida…"This is good news, because we did not reach a maximum tolerated dose, meaning that the drug is well tolerated," says the study's lead investigator, Robert Smallridge, M.D., an endocrinologist who treats patients with thyroid cancer.

Additional coverage: Science Daily



Tags: anaplastic thyroid cancer, clinical trial, Dr. Robert Smallridge, HealthCanal, Mayo Clinic Jacksonville, Research, thyroid cancer, treatment

Contact Us · Privacy Policy